BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Bio NC

  PPD, Inc. Renews Commitment To PPD Beach2Battleship Triathlon

  October 24, 2014

   · 

  1 min read
• Drug Development

  Aduro Biotech Presents Updated Interim Results From Phase 1b Clinical Trial In Mesothelioma At International Mesothelioma Interest Group Conference

  October 24, 2014

   · 

  4 min read
• BioCapital

  CEL-SCI Announces Closing Of Public Offering For Gross Proceeds Of $6 Million

  October 24, 2014

   · 

  1 min read
• Astellas Pharma Inc.'s XTANDI™ (Enzalutamide) Capsules Receive Positive CHMP Opinion For The Treatment Of Men With Metastatic Castration-Resistant Prostate Cancer Who Are Chemotherapy-Naïve

  October 24, 2014

   · 

  5 min read
• Business

  BIOCOM Announces 2014 Elected Official Of The Year

  October 24, 2014

   · 

  2 min read
• FDA

  Europe Approves Clinuvel’s Novel Australian Drug Developed For Rare Sun Disease

  October 24, 2014

   · 

  3 min read
• Glythera Unveils ADC Cysteine Linker Technology

  October 24, 2014

   · 

  5 min read
• Business

  Medivation, Inc. Licenses Clinical Stage Anti-PD-1 Immune Modulatory Monoclonal Antibody From CureTech Ltd. For Potential Applications In Oncology

  October 24, 2014

   · 

  4 min read
• Business

  Sensient Technologies Corporation Reports Results For The Quarter Ended September 30, 2014

  October 24, 2014

   · 

  1 min read
• Pharm Country

  Alexion Pharmaceuticals Inc. Release: Researchers To Present Data On Soliris® (Eculizumab) As A Treatment For Patients With Ahus At American Society of Nephrology 2014 Annual Meeting

  October 24, 2014

   · 

  1 min read